Skip to content
  • Sunday, 26 July 2026
  • 2:52 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Weekly Gilead and Merck oral HIV regimen maintains suppression in two phase 3 trials
Laboratory Automation & Robotics

Weekly Gilead and Merck oral HIV regimen maintains suppression in two phase 3 trials

Lana Keisha Jul 21, 2026 0

Recent findings presented at the 26th International AIDS Conference have underscored a significant advancement in HIV treatment, with an investigational…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu May 23, 2026 0

The World Health Organization (WHO) has unveiled a suite of groundbreaking recommendations aimed at revolutionizing tuberculosis (TB) diagnostics, promising faster,…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu May 16, 2026 0

The World Health Organization (WHO) has unveiled a groundbreaking set of new recommendations designed to fundamentally transform tuberculosis (TB) diagnostics,…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.

Reynand Amr Wu May 8, 2026 0

The global fight against tuberculosis (TB), a persistent and devastating infectious disease, has reached a critical juncture with the World…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu May 1, 2026 0

The World Health Organization (WHO) has unveiled groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, aiming for faster, more…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.

Reynand Amr Wu Apr 24, 2026 0

The World Health Organization (WHO) has unveiled a suite of groundbreaking recommendations aimed at revolutionizing tuberculosis (TB) diagnostics, emphasizing speed,…

Read More
Pharmaceutical R&D

Idvynso Secures FDA Approval, Charting a New Course in HIV Treatment While Biktarvy Maintains Market Dominance

Teuku Ryan Apr 23, 2026 0

MSD (Merck & Co) has achieved a significant milestone in the fight against Human Immunodeficiency Virus (HIV) with the U.S.…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.

Reynand Amr Wu Apr 17, 2026 0

The global landscape of tuberculosis (TB) diagnostics is undergoing a significant transformation following new recommendations issued by the World Health…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States

Reynand Amr Wu Apr 9, 2026 0

The global fight against tuberculosis (TB) has reached a pivotal juncture, with the World Health Organization (WHO) unveiling transformative new…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu Apr 1, 2026 0

The World Health Organization (WHO) has unveiled a set of groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, emphasizing…

Read More
Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trialTulane University Researchers Uncover Atomic Secrets Behind Golds Eternal Brilliance and Its Future in Clean EnergyDrexel University Researchers Engineer High-Conductivity MXene Nanoscrolls Marking a Significant Leap in One-Dimensional NanotechnologyThe Critical Role of Oxygen Levels During Planetary Core Formation in Determining Life’s Potential
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ